Oral Surgery Practice Valuation (2025 Update)
By Published On: December 14, 2025
Expert Analysis

Oral Surgery Practice Valuation

Oral surgery has emerged as a stable, high-demand segment within healthcare services M&A, combining procedural volume, anesthesia-enabled care, and diversified revenue streams that position it alongside other premium outpatient specialties. Investors continue to favor practices with strong referral networks, predictable throughput, and hybrid revenue models that balance private-pay procedures with medically necessary care.

While macro headwinds have pressured some discretionary healthcare segments, oral surgery has remained resilient. Multiple industry reports point to sustained investor appetite for procedural, high-utilization ambulatory care. Bain’s Global Healthcare Private Equity Report (2026) confirmed that healthcare PE reached a record high in global deal value in 2025, with deal count posting the second-highest annual total on record, and providers anchored that activity. Oral surgery fits firmly within this high-performing group.

 

What You Will Learn in This Report

This report covers:

How oral surgery practices are currently valued across platform and add-on transactions in 2026

Which market trends are shaping pricing in procedural specialties

The factors that push oral surgery practices toward the upper or lower end of valuation ranges

How scale, anesthesia capabilities, referral density, and operational maturity influence buyer demand

What practice owners can do to position their groups for premium outcomes in a competitive M&A market

 

2026 Valuation Benchmarks

Practices with anesthesia infrastructure, multi-location density, deep provider rosters, and meaningful procedural volume align more closely with platform-level specialty physician groups. Smaller offices with limited management systems typically fall into the add-on category.

These ranges reflect valuation behavior seen across procedural specialties in 2025–2026, including GI, ophthalmology, dermatology, cardiology, dental services, and other clinical subspecialties tracked by PitchBook, Bain, VMG Health, and Scope Research.

 

Oral Surgery Valuation Ranges

Category Platform (EV/EBITDA) Add-On (EV/EBITDA) Typical Revenue Multiple Key Drivers of Premium Valuation
Oral Surgery 10–13× 5–8× ~1.0–1.6× Anesthesia capabilities, high-margin procedures, referral density, ASC partnerships, clinical throughput, provider roster, compliance infrastructure

Source: Works cited combined with guidance from internal bankers, based generally on knowledge and experience. Actual pricing varies with each transaction based on many factors. Intended for educational purposes only and not a guarantee of any outcome.

 

Market Dynamics in 2026

Across healthcare services, investor behavior continues to shift toward operational discipline, selective capital deployment, and defensible service-line economics. PitchBook’s Q1 2026 Healthcare Services Report identifies continued strength in behavioral health, dental, and home-based care, subsectors that share key traits with oral surgery, including recurring patient flow and predictable utilization. While overall healthcare services PE deal count declined approximately 16% year-over-year in Q1 2026 from robust Q1 2025 levels, analysts expect volumes to improve through the remainder of the year as pent-up assets reach the market.

Another noticeable trend across healthcare services is the rising share of PE-backed practices held for more than five to seven years. PitchBook data shows that over 70% of PPM assets now fall into this category, suggesting meaningful pent-up supply that has begun moving to market in 2026. Bain’s 2026 report specifically notes the return of sponsor-to-sponsor activity as a key mechanism through which these assets are being transitioned to new ownership.

Broader macro dynamics shaping valuation include:

Stabilizing deal volume following the correction of 2022–2023 and the Q1 2026 cooling

Reduced bid–ask spreads as valuations normalize across the mid-market

Strong performance among provider organizations, particularly those with procedural margins

Increased carve-out activity as strategics and payers divest non-core assets

Heavy PE involvement in mid-market provider roll-ups, which remains the dominant transaction model

Growing emphasis on AI-enabled operations, with PwC noting that tech-enabled care and physician specialty platforms are drawing some of the most aggressive capital flows in years

Reports from Bain and VMG Health indicate that mid-market sponsors have continued to outperform through specialization and disciplined add-on integration, both of which directly influence how oral surgery assets are underwritten, priced, and scaled.

Unlike gastroenterology, which has seen deal activity freeze due to GLP-1 drug effects, oral surgery has experienced no similar headwinds, reinforcing its position as one of the most resilient procedural specialties.

 

What Drives Premium Valuations in Oral Surgery

Several consistent factors influence whether practices achieve the upper end of valuation ranges:

 

1. Anesthesia & Sedation Infrastructure

Oral surgery practices offering in-house anesthesia typically command higher valuations due to:

Expanded procedure eligibility

Lower cancellation rates

Higher case acceptance

Increased throughput and revenue capture

VMG Health notes that anesthesia-enabled procedural care continues to outperform other outpatient categories due to margin stability and predictable utilization. PwC’s 2026 Health Services Deals Outlook specifically highlights ambulatory surgery centers, a category aligned with oral surgery’s infrastructure model, as commanding strong multiples due to perceived scalability and favorable reimbursement direction.

 

2. Procedural Mix and Margin Profile

Oral surgery includes both medically necessary and elective procedures.

Practices with:

High case volumes

Implant services

Third-molar extractions

Bone grafting

Trauma and medically indicated procedures

…are viewed as more defensible and more predictable, supporting premium multiples.

PitchBook’s Q1 2026 analysis continues to note heightened scrutiny around Medicaid exposure following recent eligibility and rebate policy shifts. However, these pressures have had limited impact on oral surgery due to its procedural mix and comparatively low reliance on government reimbursement.

 

3. Referral Patterns and Geographic Density

Similar to orthodontics and pediatric dentistry, referral and geographic density are major factors.

Buyers reward practices that have:

Stable, multi-year referral relationships

Proximity to general dentists, pediatric dentists, or orthodontists

Multi-site clusters that support shared staffing and centralized operations

Regional density is a key determinant of scalability and integration potential for PE-backed platforms. Bain’s 2026 report on new models of value creation for physician groups reinforces that network defensibility (the ability to protect and grow referral density within a defined geography) is increasingly viewed as a standalone valuation driver.

 

4. Facility Modernization and Digital Integration

VMG Health’s 2026 Healthcare M&A Report continues to emphasize that technology-enabled dental and surgical practices exhibit higher margin durability.

For oral surgery, differentiators include:

Digital imaging and CBCT

Centralized practice management systems

Digital charting and electronic prescribing

Integrated RCM and analytics tools

AI-assisted workflow tools, including scheduling automation, coding review, and clinical documentation support, which are increasingly viewed by acquirers as evidence of scalable infrastructure

Digitally mature practices typically produce cleaner, more defensible EBITDA, and, per PwC, are more likely to attract both strategic and financial buyers in the current environment.

 

5. Compliance, Credentialing & Workforce Stability

State-level scrutiny around sedation, facility safety, and ownership disclosure continues to rise. As noted across VMG Health and PitchBook reporting, compliance infrastructure is increasingly viewed as a valuation-critical element, not a secondary consideration.

Key valuation advantages include:

Documented sedation credentialing

Updated OSHA and emergency protocols

Strong clinical retention and succession planning

Clear provider compensation models

Practices with robust governance systems reduce diligence risk and attract more competitive bidding.

 

How Scale Impacts Valuation

Consistent with wider trends in 2025–2026 healthcare M&A, scale remains one of the strongest predictors of valuation outcomes. Patterns observed across Scope Research datasets, PitchBook’s Q1 2026 comp sheets, and FOCUS benchmarks show:

 

Oral Surgery Scale and Valuation

EBITDA Scale Typical Valuation Range (EV/EBITDA) Common Characteristics
Under $1M 5–7× Single-site, limited infrastructure, owner-dependent
$1–3M 7–9× Multi-provider, early-stage systems, growing referral base
$3–5M 9–11× Multi-site, anesthesia capabilities, emerging platform
$5M+ 11–13× Platform-ready, strong operations, expansion capacity

Source: Works cited combined with guidance from internal bankers, based generally on knowledge and experience. Actual pricing varies with each transaction based on many factors. Intended for educational purposes only and not a guarantee of any outcome.

Incremental EBITDA growth often results in valuation step-ups, rather than linear movement, particularly at the $2M+, $3M+, and $5M+ thresholds commonly used by sponsors during acquisition screening.

 

Growth Pathways Evaluated by Buyers

Buyers may underwrite forward performance, making credible expansion planning a major influence on valuation. Across PitchBook and Bain analyses, platforms that demonstrate clear, achievable growth pathways consistently command premium multiples. Bain’s 2026 report specifically identifies practices that are building performance-driven platforms for the long term, rather than relying on financial engineering alone, as the assets most likely to achieve strategic exits at premium valuations.

 

Organic Growth Levers

Provider recruitment with defined ramp models

Expanded operating hours or block-time efficiency improvements

CBCT and imaging integration to increase case acceptance

Workflow automation and centralized scheduling

Enhanced referral management

AI-assisted documentation and coding to improve throughput and revenue capture

 

Inorganic Expansion Opportunities

Tuck-in acquisitions of single- or two-location OMS practices

Expansion into contiguous metropolitan areas

Partnership or co-development of anesthesia services

Strategic alignment with dental and orthodontic groups

Potential ASC partnerships or office-based surgical suites

 

Preparing for a Premium Valuation

Buyers consistently reward practices that show clear financial reporting, reliable systems, and scalable infrastructure. The table below summarizes the core areas that influence valuation outcomes and how each one shapes buyer perception during diligence.

 

Premium Valuation Preparation Checklist

Focus Area What Buyers Look For Why It Matters
Financial Optimization Normalized EBITDA at fair-market provider compensation; removal of personal or one-time expenses; clear and defensible add-backs; pro formas that reflect operational reality Creates a credible earnings baseline, reduces diligence friction, and strengthens trust in the financial model
Operational Excellence Documented SOPs for intake, scheduling, and treatment; consistent KPI tracking (case volume, no-shows, referral origin, OR efficiency); transparent coding, billing, and collections processes Demonstrates maturity, stability, and predictable performance; qualities that support higher multiples
Clinical Systems & Compliance Current sedation logs; complete credentialing files; OSHA/HIPAA compliance; updated emergency-response protocols; structured provider retention agreements Reduces regulatory risk and signals strong governance, which buyers increasingly require
Scalable Infrastructure Centralized RCM; analytics and communication platforms; digital charting; integrated imaging; sufficient management depth beyond physician leadership; AI-assisted administrative tools Shows that the practice can scale, integrate easily post-close, and support long-term growth under a platform

 

Requesting a Copy of This Report

FOCUS Investment Banking specializes in maximizing transaction value for healthcare practice owners through our proven quarterback approach to M&A advisory.

If you’d like to learn more about our healthcare investment banking services, you can reach out here.

 

Sources

 

Eric Yetter is an investment banker focused on healthcare provider services. Yetter has completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. His past clients include leading physician and dental groups, behavioral health companies, healthcare facilities, and institutional healthcare investors.